---
title: "Telo Genomics reports positive interim data for blood test predicting multiple myeloma relapse risk"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292894406.md"
description: "Telo Genomics reported positive interim data from a retrospective study on a blood-based assay for predicting multiple myeloma relapse risk. Analyzing 50 patients, the 'Average Distance to Nuclear Center' metric showed strong predictive power with an AUC of 0.849. The trial is expected to conclude in summer 2026 to validate the platform against established MRD approaches."
datetime: "2026-07-16T11:02:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292894406.md)
  - [en](https://longbridge.com/en/news/292894406.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292894406.md)
generator: "portal-rs"
---

# Telo Genomics reports positive interim data for blood test predicting multiple myeloma relapse risk

-   Telo Genomics released positive interim results from a retrospective multiple myeloma study on a blood-based relapse-risk assay using genomic instability measures. \* Interim analysis covered 50 patients with two-year outcomes; “Average Distance to Nuclear Center” was the strongest relapse-status predictor. \* ROC analysis showed AUC 0.849, indicating strong discrimination between patients who relapsed versus those who remained in remission. \* Trial is expected to conclude in summer 2026, supporting plans to validate the platform against established MRD approaches. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Telo Genomics Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202607160700NEWSFILECNPR\_\_\_\_20260716\_305392\_1) on July 16, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [TELO.US](https://longbridge.com/en/quote/TELO.US.md)

## Related News & Research

- [Pebble Flow electric RV towed by TELO’s MINI-sized electric truck](https://longbridge.com/en/news/292653926.md)
- [Telo Genomics files US provisional patent for TeloView liquid biopsy MRD algorithm in multiple myeloma](https://longbridge.com/en/news/292188448.md)
- [Telomir Shareholders Approve Equity Plan and Bylaw Changes](https://longbridge.com/en/news/280852325.md)
- [Telomir Pharmaceuticals (NASDAQ:TELO) Releases Quarterly Earnings Results](https://longbridge.com/en/news/295856128.md)
- [Telomir Reports Peer-Reviewed Preclinical Telomir-Zn Data Showing Dose-Dependent Survival & Reduced Hepatic Copper](https://longbridge.com/en/news/287061178.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**